Abstract:Mechanical loading up‐regulates the expression of PGE2, which binds to EP2 to inhibit TGFβ signalling through a CYLD‐dependent proteasome mechanism, thereby inhibiting the transactivation of pSmad2/3 and subsequently inhibiting the expression of Sost. The phosphorylation of USP4 by Ck2 can also inhibit the transcription of Sost by inhibiting ubiquitination degradation of SIRT1. Sost then acts as an antagonist of WNT/β‐catenin signalling and a promoter of RANK/RANKL signalling to modulate bone remodelling. In addition, USP53 is involved in the regulation of osteoblast–osteoclast coupling. Mechanistically, USP53 inhibits the interaction between Smad3 and VDR in osteoblasts, resulting in reduced binding of VDR to its cognate elements, thereby inhibiting the activation of RANKL. Osteoporosis is an ageing‐related disease, that has become a major public health problem and its pathogenesis has not yet been fully elucidated. Substantial evidence suggests a strong link between overall age‐related disease progression and epigenetic modifications throughout the life cycle. As an important epigenetic modification, ubiquitination is extensively involved in various physiological processes, and its role in bone metabolism has attracted increasing attention. Ubiquitination can be reversed by deubiquitinases, which counteract protein ubiquitination degradation. As the largest and most structurally diverse cysteinase family of deubiquitinating enzymes, ubiquitin‐specific proteases (USPs), comprising the largest and most structurally diverse cysteine kinase family of deubiquitinating enzymes, have been found to be important players in maintaining the balance between bone formation and resorption. The aim of this review is to explore recent findings highlighting the regulatory functions of USPs in bone metabolism and provide insight into the molecular mechanisms governing their actions during bone loss. An in‐deep understanding of USPs‐mediated regulation of bone formation and bone resorption will provide a scientific rationale for the discovery and development of novel USP‐targeted therapeutic strategies for osteoporosis.

Deubiquitinating Enzymes and Bone Remodeling

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

The Deubiquitinase UCHL1 Negatively Controls Osteoclastogenesis by Regulating TAZ/NFATC1 Signalling

Role of Ubiquitination in the Occurrence and Development of Osteoporosis (Review)

The Role of Deubiquitinating Enzymes in Primary Bone Cancer

Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases

Ubiquitin‐specific peptidases: Players in bone metabolism

E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation

Regulation of Deubiquitinating Enzymes by Post-Translational Modifications

Deubiquitinases in skeletal muscle - The Underappreciated Side of the Ubiquitination Coin

The roles of bone‐derived exosomes and exosomal micro<scp>RNA</scp>s in regulating bone remodelling

Osteoblastogenesis Regulation Signals in Bone Remodeling

Mechanical regulation of bone remodeling

The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling

Cellular and Molecular Aspects of Bone Remodeling

The Role of E3 Ubiquitin Ligase Smurfs in Bmp and Tgf-Bata Signaling in Bone Cells

Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code

Deubiquitylating Enzymes in Cancer and Immunity

TGF-β signaling pathway mediated by deubiquitinating enzymes

The Regulation of E3 Ubiquitin Ligases Cbl and its Cross-talking in Bone Homeostasis

Structure and Function of the Highly Homologous Deubiquitinases Ubiquitin Specific Peptidase 25 and 28: Insights into Their Pathophysiological and Therapeutic Roles.